Clinical trial
Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced…
NCT00002973 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00002973 |
|---|---|
| Title | Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma |
| Official title | Phase II Evaluation of IV Melphalan (L-PAM) and Whole Body Hyperthermia (WBH) for Malignant Melanoma |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Drug, Procedure |
| Interventions | melphalan, hyperthermia treatment |
| Enrollment | 34 |
| Start date | Dec 1, 1995 |
| Primary completion | May 1, 2000 |
| Completion | Dec 1, 2000 |
| First posted | Jun 16, 2004 |
| Last update posted | Oct 2, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: